MIDBIT

The Multi-Institution Double-Blind in vivo Trials (MIDBIT) is an educational resource developed by SWIRL aimed at providing students with hands-on in vivo experience replicating a multi-centre in vivo drug trial. As far as we know, it is the world's only student-led drug trial. 

Further information on MIDBIT is available below, with this teaching initiative forming the basis of our 2023 publication in Pharmacology Research & Perspectives, entitled "Co-created in vivo pharmacology practical classes using the novel organism Lumbriculus variegatus", and our 2025 publication in Advances in Physiology Education, entitled "How to get physiologically relevant data with students using Lumbriculus variegatus"